Enteric disease is a condition caused in the intestine due to the presence of foreign antigen such as bacterial, viral and parasites. The enteric diseases are commonly caused due to E-coli, Vibro Cholerae salmonella, shigella, rotavirus, and norovirus. The most influencing factor being hygiene is getting worst due to the increasing population, especially in urban areas of developing economies. Several factors such as unsafe drinking water, poor sanitation and unhygienic conditions are increasing the prevalence of enteric diseases. In order to overcome the severity of these diseases, the companies are shifting their trends from conventional to more advance diagnostics and treatments. The companies are adopting various strategies for the development of novel therapeutics and testing technologies for enteric diseases. The report analyzes these key strategies of leading players. Government regulation and reimbursement scenarios for the enteric disease are dealt according to geographies. The enteric disease testing market’s external environment has been studied in order to provide intelligence to decision markers.
The market enteric disease testing market is hindered due to high cost of equipments and labors, and mandatory requirement for sophisticated laboratory conditions for clinical diagnostics. These challenges are expected to be resolve in future with the emergence of various advance cost effective technologies such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR). Furthermore, increase in intervention from the governments to improve the living standard in people is expected to influence the market positively. The government authorities are chiefly responsible for shifting the trend of conventional diagnostic to advance methods.
Global Enteric Disease Testing Therapeutics Market
Global enteric disease testing therapeutics market is segmented into Campylobacter, Cryptosporidium, E-Coli, Enteroviruses, RhinoViruses, RotaVirus (REOVIRUS), Salmonellosis and Shigellosis. E-coli is the leading bacteria that cause the enteric disorders among children.
Global Enteric Disease Testing Technology Market
Global enteric disease testing technology market is segmented into, Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, Differential Light Scattering, Information Technology, Artificial Intelligence, Liposomes, Flow Cytometry, Chromatography , Diagnostic Imaging, Gel Microdroplets and Others. The molecular diagnostics is the emerging technology in enteric diseases and it is expected to be the fastest growing compared to other technologies.
Global Enteric Disease Geography Testing Market
Global enteric disease testing market by geography is segmented into North America, Europe, Asia-Pacific and LAMEA. Asia-Pacific is currently dominating the market with more than 50% of market share. This is due to increase in migration of people from rural areas to urban.
Key players operating in testing and therapeutics market are adopting product launch and approval for the commercialization of novel technologies. These companies are investing in research and development to advance the testing technologies in order to increase the efficiency of diagnosis. Key companies included in the report are Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., Biomerieux, Bio-Rad, Cepheid Coris Bioconcept, Diasorin, Meridian Bioscience, Inc, Quest Diagnostics and Trinity Biotech.
High Level Analysis
Enteric Disease Testing Market is an emerging market that has accelerated the growth of rapid diseases diagnosis for enteric diseases. These technologies are strategically analyzed in the report in order to provide comparative benefits. The report is also concentrating on the regulatory issues that are hindering the growth. Porter’s five force model is strategically dealt in the report to project the market trends. The value chain analysis of the Enteric Disease Testing Market is dealt strategically. Top investment pocket for Enteric Disease Testing technology market show the impact of growth factors. Top wining strategies adopted by the key players competing in this market are critically analyzed through primaries.
The global Enteric Disease Testing Market is segmented into testing types, technologies and geography.
MARKET BY THERAPEUTICS
MARKET BY TECHNOLOGIES
MARKET BY GEOGRAPHY
SIMILAR MARKET STUDIES
DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017-2023
DNA sequencing is a molecular technique, which help to determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $5,156 million in 2016, and is anticipated to reach $18,284 million by 2023, ...
May 2017 | $5370 | View Details >>
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such Alzheimerâ€™s disease, Parkinson disease, and other neurological disorders.
May 2017 | $5370 | View Details >>
Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-BarrÃ© Syndrome, Kawasaki Disease, Secondary Immune Deficiency, And Other Applications), Mode of Delivery (Intravenous, Intramuscular, Subcutaneous), and Concentration (5%, 10% and Other Concentration): Opportunity Analysis and Industry Forecast, 2014-2022
Intravenous immunoglobulin (IVIG) is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. IVIG is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology.
May 2017 | $2850 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research